Understanding usual care for patients with multimorbidity: baseline data from a cluster-randomised trial of the 3D intervention in primary care

BMJ Open
Katherine ChaplinChris Salisbury

Abstract

Recent evidence has highlighted the high prevalence and impact of multimorbidity, but the evidence base for improving management is limited. We have tested a new complex intervention for multimorbidity (the 3D model). The paper describes the baseline characteristics of practices and patients in order to establish the external validity of trial participants. It also explores current 'usual primary care' for multimorbidity, against which the 3D intervention was tested. Analysis of baseline data from patients in a cluster-randomised controlled trial and additional data from practice staff. Primary care in the UK. Patients with multimorbidity (n=5253) and 154 practice staff. Using surveys and routinely available data, we compared the characteristics of participating and non-participating practices and participating and non-participating eligible patients.Baseline questionnaire data from patient participants was used to examine participant illness burden, treatment burden and perceptions of receiving patient-centred care. We obtained data about usual care preintervention from practice staff using questionnaires and a structured pro forma. Participating practices were slightly larger, in less deprived areas, and with slightly higher ...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Sep 27, 2000·Social Science & Medicine·N Mead, P Bower
Feb 27, 2001·BMJ : British Medical Journal·M Stewart
Apr 20, 2005·Medical Care·Russell E GlasgowSarah M Greene
Oct 1, 2008·BMJ : British Medical Journal·Peter CraigUNKNOWN Medical Research Council Guidance
Aug 13, 2009·BMJ : British Medical Journal·Carl MayFrances S Mair
Mar 16, 2011·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Chris SalisburyAlan A Montgomery
Sep 22, 2012·Journal of the American Geriatrics Society·UNKNOWN American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity
Apr 9, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Chris Salisbury
May 15, 2013·BMJ : British Medical Journal·Anne KennedyUNKNOWN Salford National Institute for Health Research Gastrointestinal programme Grant Research Group
Sep 3, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·David ReevesPeter Bower
Nov 15, 2014·BMJ : British Medical Journal·Zosia Kmietowicz
Dec 9, 2014·BMC Medicine·Christiane MuthPaul P Glasziou
May 10, 2015·BMJ : British Medical Journal·Kirsty LoudonMerrick Zwarenstein
Aug 19, 2015·Nursing & Health Sciences·Susanne GarvisColleen Meyer
Mar 16, 2016·The Cochrane Database of Systematic Reviews·Susan M SmithMartin Fortin
Mar 28, 2017·PloS One·Floor J van DeudekomSimon P Mooijaart
May 16, 2017·Journal of Clinical Epidemiology·Sally D WorsleyUNKNOWN GetReal Work Package 3
Oct 3, 2017·Health Policy·Katie PalmerUNKNOWN Joint Action on Chronic Diseases and Promoting Healthy Ageing Across the Life Cycle (JA-CHRODIS)
Nov 15, 2017·Annals of Family Medicine·Jonathan StokesPeter Bower

❮ Previous
Next ❯

Citations

Sep 6, 2020·BMC Family Practice·E LautamattiK J Mattila
Sep 30, 2021·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Xiu-Jing HuStewart W Mercer

❮ Previous
Next ❯

Software Mentioned

Excel
EMIS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.